Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Prostate Cancer

  Free Subscription


Articles published in Prog Urol

Retrieve available abstracts of 41 articles:
HTML format
Text format



Single Articles


    May 2018
  1. RAICHI A, Marcq G, Fantoni JC, Puech P, et al
    [Active surveillance in prostate cancer: Assessment of MRI in the selection and follow-up of patients].
    Prog Urol. 2018 May 31. pii: S1166-7087(18)30085.
    PubMed     Text format     Abstract available


  2. HACHI K, Boualga K, Chettibi K, Harouni M, et al
    [Study of the beneficial effects of triptorelin on lower urinary tract symptoms in Algeria in patients with non-localized prostate cancer].
    Prog Urol. 2018 May 20. pii: S1166-7087(18)30094.
    PubMed     Text format     Abstract available


  3. MARTIN-MALBURET A, Marcq G, Leroy X, Guiffart P, et al
    [Pathology findings after radical prostatectomy for prostate cancer in patients eligible for active surveillance: Contribution of multiparametric MRI to treatment decision].
    Prog Urol. 2018 May 20. pii: S1166-7087(18)30092.
    PubMed     Text format     Abstract available


    April 2018
  4. ROZET F, Hennequin C, Mongiat-Artus P, Beuzeboc P, et al
    [French CCAFU guidelines on prostate cancer: hormono-naive metastatic prostate cancer - update 2017].
    Prog Urol. 2018 Apr 18. pii: S1166-7087(18)30080.
    PubMed     Text format    


    March 2018
  5. GEVORGYAN A, Hetet JF, Robert M, Duchattelle-Dussaule V, et al
    [Salvage cryotherapy of prostate cancer after failed external radiotherapy and brachytherapy: Morbidity and mid-term oncological results].
    Prog Urol. 2018 Mar 15. pii: S1166-7087(17)30543.
    PubMed     Text format     Abstract available


    December 2017
  6. DE LA TAILLE A, Mardoyan S, Lafaye A
    [Psychological impact of prostate cancer on patients receiving a 6-month androgen deprivation therapy].
    Prog Urol. 2017 Dec 6. pii: S1166-7087(17)30625.
    PubMed     Text format     Abstract available


  7. DE VERGIE S, Gaschignard N, Baron M, Branchereau J, et al
    [Long-term outcomes of prostate cancer patients with lymph nodes metastasis after radical prostatectomy and pelvic lymph node dissection].
    Prog Urol. 2017 Dec 5. pii: S1166-7087(17)30624.
    PubMed     Text format     Abstract available


    November 2017
  8. DEFONTAINES J, Salomon L, Champy C, Cholley I, et al
    [Prostate cancer diagnostic by saturation randomized biopsy versus rigid targeted biopsy].
    Prog Urol. 2017 Nov 6. pii: S1166-7087(17)30536.
    PubMed     Text format     Abstract available


    September 2017
  9. RENARD-PENNA R, Sanchez-Salas R, Barret E, Cosset JM, et al
    [Evaluation and results of ablative therapies in prostate cancer].
    Prog Urol. 2017 Sep 19. pii: S1166-7087(17)30455.
    PubMed     Text format     Abstract available


  10. BARRET E, Sanchez-Salas R, Galiano M, Cathala N, et al
    [Management of ablative therapies in prostate cancer].
    Prog Urol. 2017 Sep 14. pii: S1166-7087(17)30411.
    PubMed     Text format     Abstract available


  11. SANCHEZ-SALAS R, Barret E, Renard-Penna R, Cosset JM, et al
    [Indications and limits of ablative therapies in prostate cancer].
    Prog Urol. 2017 Sep 14. pii: S1166-7087(17)30456.
    PubMed     Text format     Abstract available


    June 2017
  12. MARIEN A, De Castro Abreu A, Gill I, Villers A, et al
    [Interest using 3D ultrasound and MRI fusion biopsy for prostate cancer detection].
    Prog Urol. 2017 Jun 16. pii: S1166-7087(17)30130.
    PubMed     Text format     Abstract available


    May 2017
  13. VIDMAR R, Marcq G, Flamand V, Fantoni JC, et al
    [Salvage radical prostatectomy for recurrent prostate cancer. Morbidity, oncological and functional results].
    Prog Urol. 2017 May 30. pii: S1166-7087(17)30108.
    PubMed     Text format     Abstract available


  14. GIRIER D, Chevrot A, Costa P, Thuret R, et al
    [Sexual consequences after treatment of prostate cancer: Inquiry among members of the Association Nationale des Malades du Cancer de la Prostate].
    Prog Urol. 2017 May 5. pii: S1166-7087(17)30075.
    PubMed     Text format     Abstract available


    April 2017
  15. MONDET F, Alimi JC, Boyer C
    [Cancer plans apply to surgical treatment of prostate cancer: A geographically isolated center balance].
    Prog Urol. 2017 Apr 6. pii: S1166-7087(17)30046.
    PubMed     Text format     Abstract available


  16. ROZET F, Roupret M, Hennequin C, Massard C, et al
    [Management of a progressing prostate cancer: results of a national study].
    Prog Urol. 2017 Apr 6. pii: S1166-7087(17)30022.
    PubMed     Text format     Abstract available


    March 2017
  17. LONG JA, Poinas G, Fiard G, Lepretre M, et al
    [Robot assisted radical prostatectomy: What are the evidences at the time of a specific funding?]
    Prog Urol. 2017;27:146-157.
    PubMed     Text format     Abstract available


  18. LIMANI K, Albisinni S, Aoun F, Le Dinh D, et al
    [Quality of life after robotic prostatectomy: Impact of BMI and age on urinary incontinence].
    Prog Urol. 2017;27:244-252.
    PubMed     Text format     Abstract available


    February 2017
  19. LEON P, Cancel-Tassin G, Koutlidis N, Calves J, et al
    [Prevalence and diversity of management of prostate cancer patients classified as low risk using D'Amico group or Cancer of the Prostate Risk Assessment (CAPRA) score: A French multicenter study].
    Prog Urol. 2017 Feb 28. pii: S1166-7087(17)30017.
    PubMed     Text format     Abstract available


  20. CHAHWAN C, Doerfler A, Brichart N, Bouye S, et al
    Prostate cancer before renal transplantation: A multicentre study.
    Prog Urol. 2017 Feb 22. pii: S1166-7087(17)30015.
    PubMed     Text format     Abstract available


    January 2017
  21. DAUBISSE-MARLIAC L, Lamy S, Lunardi P, Tollon C, et al
    [Prostate cancer: Quality assessment of clinical management in the Midi-Pyrenean region in 2011].
    Prog Urol. 2017 Jan 20. pii: S1166-7087(16)30779.
    PubMed     Text format     Abstract available


    December 2016
  22. MORTIER P, Bastide C, Lechevallier E, Walz J, et al
    [Oncological results of active surveillance in prostate cancer: A retrospective multicentric cohort].
    Prog Urol. 2016 Dec 13. pii: S1166-7087(16)30753.
    PubMed     Text format     Abstract available


    November 2016
  23. ROZET F, Hennequin C, Beauval JB, Beuzeboc P, et al
    [CCAFU french national guidelines 2016-2018 on prostate cancer].
    Prog Urol. 2016;27 Suppl 1:S95-S143.
    PubMed     Text format     Abstract available


  24. COHEN J, Andre C, Mozer P
    [Targeted MRI prostate biopsies].
    Prog Urol. 2016;26:854-859.
    PubMed     Text format     Abstract available


    September 2016
  25. MICHAUD L, Touijer KA
    [Focus on molecular imaging in prostate cancer].
    Prog Urol. 2016 Sep 20. pii: S1166-7087(16)30416.
    PubMed     Text format     Abstract available


    August 2016
  26. HOQUETIS L, Malavaud B, Game X, Beauval JB, et al
    MRI evaluation following partial HIFU therapy for localized prostate cancer: A single-center study.
    Prog Urol. 2016 Aug 24. pii: S1166-7087(16)30106.
    PubMed     Text format     Abstract available


  27. MERY B, Vallard A, Espenel S, Badie N, et al
    [Prostate cancer of elderly patients: Place and role of geriatric assessment].
    Prog Urol. 2016 Aug 24. pii: S1166-7087(16)30102.
    PubMed     Text format     Abstract available


    July 2016
  28. RIOUX-LECLERCQ N, Comperat E, Kammerer-Jacquet SF, Camparo P, et al
    [Pathological advances in renal, prostatic, bladder and testis neoplasia].
    Prog Urol. 2016 Jul 26. pii: S1166-7087(16)30070.
    PubMed     Text format     Abstract available


  29. LORION R, Bladou F, Spatz A, van Kempen L, et al
    [Prostate cancer microenvironment: Its structure, functions and therapeutic applications].
    Prog Urol. 2016 Jul 13. pii: S1166-7087(16)30074.
    PubMed     Text format     Abstract available


    May 2016
  30. BARRE C, Nguyen JM
    [Addendum concerning: "A prospective trial comparing consecutive series of open retropubic and robot-assisted laparoscopic radical prostatectomy in a centre: Oncologic and functional outcomes" written by J.B. Beauval et al. [Prog. Urol. 25 (2015) 370-
    Prog Urol. 2016;26:383-4.
    PubMed     Text format    


    April 2016
  31. ALBISINNI S, De Groote A, Deneft F, Thoma P, et al
    [Can preoperative prostate MRI before radical prostatectomy predict extracapsular extension and the side of the index lesion?].
    Prog Urol. 2016;26:281-6.
    PubMed     Text format     Abstract available


    March 2016
  32. PLOUSSARD G, Bruyere F, Culine S, de La Taille A, et al
    [Castration modalities in prostate cancer: Are they all equal?]
    Prog Urol. 2016 Mar 23. pii: S1166-7087(16)00071.
    PubMed     Text format     Abstract available


  33. LUNARDI P, Beauval JB, Roumiguie M, Soulie M, et al
    [Mechanisms of castration resistance: Intratumoral hypoxia stimulates the androgen receptor expression].
    Prog Urol. 2016;26:159-67.
    PubMed     Text format     Abstract available


    January 2016
  34. RUFFION A, de la Taille A
    [The ambulatory is it future of radical prostatectomy? Probably not...].
    Prog Urol. 2016;26:14-5.
    PubMed     Text format    


  35. LECLERS F, Dutheil V, Poupot D, Moalic R, et al
    [Half-day case robotic radical prostatectomy. Surgery of the future? A case report].
    Prog Urol. 2016;26:10-3.
    PubMed     Text format     Abstract available


    November 2015
  36. VLAEMINCK-GUILLEM V, Devonec M, Champetier D, Decaussin-Petrucci M, et al
    Urinary PCA3 to predict prostate cancer in a cohort of 1015 patients.
    Prog Urol. 2015 Nov 13. pii: S1166-7087(15)00689.
    PubMed     Text format     Abstract available


    June 2015
  37. ROZET F
    [A prospective trial comparing consecutive series of open retropubic and robot-assisted laparoscopic radical prostatectomy in a centre: Oncologic and functional outcomes].
    Prog Urol. 2015;25:379-80.
    PubMed     Text format    


  38. BEAUVAL JB, Roumiguie M, Ouali M, Doumerc N, et al
    [A prospective trial comparing consecutive series of open retropubic and robot-assisted laparoscopic radical prostatectomy in a centre: Oncologic and functional outcomes].
    Prog Urol. 2015;25:370-8.
    PubMed     Text format     Abstract available


  39. BALSSA L, Pastori J, Lillaz J, Panouilleres M, et al
    [Impact of obesity on pathologic outcomes and biochemical reccurence after radical prostatectomy].
    Prog Urol. 2015;25:420-7.
    PubMed     Text format     Abstract available


    March 2015
  40. RIZK J, Ouzzane A, Flamand V, Fantoni JC, et al
    [Long term biochemical recurrence free survival after radical prostatectomy for cancer: comparative analysis according to surgical approach and clinicopathological stage].
    Prog Urol. 2015;25:157-68.
    PubMed     Text format     Abstract available


    November 2014
  41. DELAGE F, Perrouin-Verbe MA, Le Fur E, Papin G, et al
    [Erectile dysfunction evaluation after brachytherapy for low risk prostate adenocarcinoma: Prospective study of patients with a baseline IIEF5>16.]
    Prog Urol. 2014 Nov 16. pii: S1166-7087(14)00624.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: